INTRODUCTION
Developments in biotechnology have led to a number of new strategies for designing and engineering vaccines. An attractive example is to fuse immunologically relevant sectors of an important protein antigen into a naturally occurring bacterial surface protein such as the structural proteins for flagella or fimbriae. Fimbriae are adhesive bacterial surface structures which enable bacteria to target and to colonize specific host tissues (for reviews see Duguid & Old, 1980; Klemm & Krogfelt, 1994 ; Krogfelt, 1991) . These are long thread-like surface ..... . .............. .......... ................. . ......... ............ .............................................................................. Abbreviations: CTB, cholera toxin B chain; DICM, differential interference contrast microscopy; FITC, fluorescein isothiocyanate. organelles, found in up to about 500 copies per cell. A large variety of fimbriae are known, and have, where this aspect has been studied, turned out to be completely non-toxic proteins only serving as colonization factors. Vaccines based on wild-type fimbriae have been highly successful, for example in protecting against various diarrhoea-causing enterotoxigenic Escherichia coli strains (Levine et al., 1994; Moon & Bunn, 1993) . Such results have indicated that fimbriae normally are very good immunogens both in the context of live vaccines and as purified proteins. Type 1 fimbriae are found on the majority of E. coli strains. A single type 1 fimbria is a thin, 7 nm wide and approximately 1 pm long, surface polymer. It consists of about 1000 subunits of a major building element, the FimA protein, stacked in a helical cylinder (Brinton, 1965) . Additionally, a small percentage of minor components are also present as integral parts of the fimbriae (Krogfelt & Klemm, 1988) . It has been shown that the minor components, FimF, FimG and FimH, are involved in fimbrial-length regulation (Klemm & Christiansen, 1987; Russell & Orndorf, 1992) . The FimH protein has been shown to be the actual receptor-binding molecule which recognizes D-mannose-containing structures (Krogfelt et al., 1990) . The FimF and FimG components seem to be required for integration of the FimH adhesin into the fimbriae. The minor components are per se not necessary for synthesis of the fimbriae, since recombinant bacteria entirely missing the corresponding genes art. able to express pure FimA fimbriae (Klemm & Christiansen, 1987 ; Krogfelt & Klemm, 31988) . However, such organelles are devoid of adherence activity.
Type 1 fimbriae are encoded by the fim gene cluster. This encompasses nine genes contained wichin a 9.5 kb DNA segment (Fig. 1) . We have studied the fim genes responsible for type 1 fimbriation of E. coli K-12 strain PC31 for a number of years and have reached a detailed understanding of the biosynthesis of these adhesive organelles. The structural components of type 1 fimbriae are produced as precursors having an N-terminal signal sequence. This element is subsequently removed during export across the inner membrane. All evidence suggests that this translocation is dependent on the normal type I1 E. coli export system, viz. SecA, SecB, et'c. (Dodd & Eisenstein, 1984 ; Pugsley, 1993) . However, further export to the cell exterior, i.e. from the periplasm and across the outer membrane, is dependent on a fimbriaespecific export and assembly system constituted by the FimC and FimD proteins. FimC is a periplasmic located chaperone that binds t o nascently translocated organelle components and prevents them from making incorrect interactions that cause aggregation and proteolytic degradation (Jones et al., 1993; Klemm, 1992; Pugsley, 1993) . FimD, a so-called usher, is found in the outer membrane and is involved in organized polymerization of the structural components into fimbrial organelles (Hultgren et al., 1993; Klemm & Christiansen, 1990; Pugsley, 1993) .
The biogenesis machinery of type 1 fimbriae has been shown to be quite tolerant in accepting similar but heterologous structural components and still assemble such into fimbriae. Thus, components from F1C fimbriae exhibiting as little as 34% identity with their equivalents in type 1 fimbriae are readily integrated into type 1 fimbriae resulting in hybrid organelles . This kind of information suggested that type 1 fimbriae could be used as carriers of heterologous sequences representing foreign epitopes. Such fimbriae consist of chimeric FimA proteins resulting from inframe fusion of the heterologous sequences into selected positions in the fimA gene. If insert positions are chosen which do not interfere with the bioassembly of the organelles, normal fimbriae, in which every subunit will carry a foreign peptide segment will result. There are several advantages of such an approach, one being the large amounts of major subunit protein and thereby foreign antigen produced, i.e. a single fimbriated cell has as many as half a million copies of FimA on its surface. al. (1996) . In short, an npt cassette flanked by DNA segments containing the upstream and downstream regions of the fim gene cluster, respectively, was used for homologous double crossover recombination. Cells were grown on solid medium or liquid broth supplemented with the appropriate antibiotics.
Plasmids. Plasmids used in this study are listed in Table 1 . Plasmid pLPA41 was made by inserting a 636 bp PCR fragment containing the fimA gene and the adjacent regions 70 bp upstream and 20 bp downstream and flanked by two SacI sites into the SacI site of plasmid pUC18. The insert was positioned downstream and in an expression-compatible orientation to the lac promoter residing on the vector part of the plasmid. Plasmids pLPA110, pLPA111, pLPA112 and pLPA119 were made by joining two individual PCR fragments in each case (see Fig. 2 ) at their BgfII sites and inserting the resulting fragment into the SacI site of plasmid pUC18. Plasmids pLPAl13, pLPAll4, pLPA115 and pLPA125 were made by inserting a 51 bp synthetic dsDNA segment encoding amino acids 50-64 of the B subunit of cholera toxin and containing a BglII overhang at one end and a BamHI overhang at the other into the BgfII site of plasmids pLPA110, pLPAl11, pLPA112 and pLPA119, respectively (cf. Figs 1 and 2) . Plasmids pLPA123, pLPA124 and pLPA126 were made by introducing a second cholera-epitope-encoding segment into the BglII sites of plasmids pLPA113, pLPA114 and pLPA125, respectively. Plasmid pLBJ312 was made as depicted in Fig. 3 .
Prediction of surface-located positions in FimA. Positions with maximum probability of surface location were chosen according to concomitant occurrence of predicted hydrophilicity maxima and /?-turns as described by Hedegaard & Klemm (1989) .
DNA techniques. Isolation of plasmid DNA was carried out by the method of Birnboim & Doly (1979) . Restriction endonucleases were used according to the manufacturer's specifications (New England Biolabs). DNA sequencing was by the dideoxy chain-termination technique (Sanger et af., 1977) using a Sequenase version 2.0 kit from USB. Oligonucleotides were made at the department's core facilities. (Klemm, 1984) were used for introduction of flanking SacI sites and an internal BglII site: P1: 5'-GTCGAGCTC-GTTTACAAA-3' ; P2 : S'-CAAGATCTGTTGATCAAA-3' ; P3 : S'-ACAGATCTTGCATCAACT-3' ; P4 : 5'-AAAGATC-TACCAGTTCTG-3' ; P5 : 5'-GTAGATCTTTCCTGTGCC-3' ; P6 : S'-CGAGATCTACCAACGTTC-3' ; P7 5'-GTAGA-TCTCGCATCAATC-3' ; P8 : 5'-ACAGATCTGGTGCTGC-GC-3' ; P9: 5'-CCAGATCTGTCCAGGATC-3' ; P10: 5'-AATGAGCTCCCTGAACCT-3'. PCR fragments were made, using primers P1-P10, as shown in Fig. 2 employing plasmid pLPA41 as template.
Haemagglutination. The capacity of bacteria to express a Dmannose-binding phenotype was assayed by their ability to agglutinate guinea-pig erythrocytes on glass slides. Aliquots of liquid bacterial cultures at OD,,, 10.0 and 5 O/O erythrocytes were mixed and the time until agglutination occurred was measured.
Antisera. Rabbit anti-type 1 fimbrial serum raised against purified type 1 fimbriae has previously been described (Krogfelt & Klemm, 1988) . Hyperimmune serum against cholera toxin B chain (CTB) was obtained by immunizing a rabbit with CTB (Sigma). Aliquots of 20 pl of a solution of 1 mg CTB ml-l in Freund's incomplete adjuvant were given intravenously every fifth day over a 7 week period, after which the animal was bled. Fluorescein isothiocyanate (FITC) conjugated anti-rabbit serum was supplemented by Dako, Denmark.
Western blot (immunoblot).
Samples were subjected to sodium dodecyl sulfate-polyacrylamide (15 ' / o ) gel electrophoresis and transferred to PVDF microporous membrane filters using a semi-dry blotting apparatus. Filters were processed as previously described (Hedegaard & Klemm, 1989; Krogfelt & Klemm, 1988) . Serum raised against either wild-type or chimeric fimbriae or CTB, respectively, was used as the primary serum and peroxidase-conjugated anti-rabbit serum was used as the secondary serum. Microscopy and image analysis. Differential interference contrast microscopy (DICM) and image analysis was carried out as described by Pallesen et af. (1995) .
Electron microscopy. Electron microscopy and immunoelectron microscopy were carried out essentially as described previously Pallesen et al., 1995) . In short
a LO p1 aliquot of bacterial suspension was placed on a carboncoated, glow discharged grid for 30 s. Grids were washed in two drops PBS, dehydrated in increasing concentrations of ethanol, blotted dry, and shadowed with tungsten. For immunoelectron microscopy, a mixture of an ti-CTB rabbit serum (diluted 1:lOO) and a monoclonal mouse anti-FimA serum (diluted 1 :5) was used as the primary antiserum, and anti-rabbit and anti-mouse serum conjugated with colloidal gold particles, of 10 nm and 5 nm diameter, respectively (BioCell), were used as the secondary antibody. The monoclonal anti-FimA serum was a generous gift from Karen Krogfelt, State Serum Institute, Denmark.
Immunization with fimbriae. Fimbriae were purified essentially as previously described (Hedegaard & Klemm, 1989) , the only change being that precipitation of fimbriae from the crude extract was performed in 20% (w/v) ammonium sulfate. Purified fimbriae were used to immunize rabbits. T w o animals were immunized with purified chimeric (FimA-CTB) fimbriae, and one animal was immunized with wild-type type 1 fimbriae (control), respectively. Three doses of a suspension of 0.1 ml 0.5 mg fimbriae ml-l mixed with equal parts of Freund's incomplete adjuvant were administered subcutaneously at 2 week intervals. Blood was collected from animals before immunization and after 3, 6 and 9 weeks.
RESULTS

Research strategy
In a preliminary study (Hedegaard & Klemm, 1989) heterologous DNA segments, encoding consensus sequences for restriction enzymes or, in a few cases, mimicking foreign epitopes, were inserted into naturally available restriction sites in the fimA gene which were unique in the context of all or large parts of the fim gene cluster. Such an approach only permits insertion into a few positions which might not be optimal for harbouring heterologous sequences. The present work relies on a different strategy, viz. introduction of restriction sites by PCR technology. Such an approach offers the possibility to engineer any position of choice in the ,fimA gene to contain unique restriction sites which in turn can be used for insertion of heterologous sequences representing foreign epitopes. In this work, initial genetic manipulations of the fimA gene were carried out on plasmid vectors that uniquely contained this gene. T o avoid cumbersome binary plasmid systems, all manipulated fimA chimeras were subsequently moved into the context of the total fim gene cluster on a single plasmid.
Engineering new restriction sites into fimA
Based on algorithms for prediction of such parameters as hydrophilicity and secondary structure, five positions, corresponding to 25, 45, 60, 80 and 105 in the mature FimA protein were predicted to have maximum probability of surface-exposure in the protein. One of these, position 60, is proximal to a cysteine residue known to be involved in the intramolecular S,,-S,, (Fig. 2 ) .
The introduced BglII sites did not result in any change in the number of amino acids, but did cause a few codon changes. Sequence analysis of the entire modified fimA genes in plasmids pLPA110, pLPA119, pLPAlll and pLPA112 confirmed that no other changes had occurred.
Engineering heterologous DNA sequences encoding a cholera toxin epitope into four sites in fimA As a relevant heterologous reporter-epitope we have chosen a well-characterized region of the CTB. This segment consists of residues 50-64 of CTB and has previously been shown to elicit antibodies that bind to and neutralize cholera toxin (Jacob et al., 1983) .
Residues 50-64 comprise a conformational loop on the surface of CTB that is entirely conserved between CTB and the closely related heat-labile toxin of E. coli (Merrit et al., 1994; Shoham et al., 1995) . This loop is directly involved in receptor-binding of the toxin to epithelial cells (Merrit et al., 1994) . A synthetic DNA segment encoding the cholera epitope was made by annealing two complementary 51 bp oligonucleotides, which were designed, after annealing, to result in a dsDNA segment with a BglII overhang in one end, and a BamHI overhang in the other. A single copy of the epitope-encoding segment was inserted into the BglII sites in the fimA gene in plasmids pLPA110, pLPA119, pLPAlll and pLPA112, respectively, resulting in plasmids pPLAll3, pLPA125, pLPA114 and pLPA115 (Fig. 2) . Insertion of the cholera-toxin-encoding oligonucleotide resulted in regeneration of a BglII site at only one end of the insert. This feature was used to identify plasmids with correct orientation of the insert. Furthermore, this feature also permitted creation of a number of chimeras containing tandem repeats of the cholera toxin insert, i.e. plasmids pLPAl23, pLPA126 and pLPA124 (Table 1 ; Fig. 2) . Restriction enzyme and DNA sequence analysis of the chimeric plasmids, harbouring either a single or double cholera insert, confirmed the orientation and conservation of the reading frame in the chimeric fimAcholera gene.
Con st r uct ion of si ng le plasm id systems contain i ng fim gene clusters with chimeric versions of fimA T o create a cassette into which chimeric versions of the fimA gene could be easily inserted into a background of the rest of the fim genes, the fimA gene was replaced by a unique SacI restriction site resulting in plasmid pLBJ312 (Fig. 3) unable to produce fimbriae. To test the replacement system a SacI fragment from plasmid pLPA41, containing the wild-type version of the fimA gene, was introduced into the SacI site of pLBJ312 resulting in pLBJ318 (Fig. 1) . Host cells that harboured this plasmid produced type 1 fimbriae which in quality and quantity were indistinguishable from those produced by hosts containing a control plasmid (pPKL4) that harboured the non-engineered fim gene cluster (data not shown).
Since all chimeric fimA genes in plasmids pLPA113-pLPAll5 and pLPA123-pLPA126 were designed such that they were flanked by Sac1 sites, all of these cassettes were subsequently inserted into the unique SacI site of pLB 5312, resulting in plasmids pBSO1-pBSO 7, respectively (Table 1 , Fig. 1 ).
Expression of chimeric FimA and chimeric type 1 fimbriae
The ability of E. coli hosts, which contained plasmids encoding chimeric fimA genes, to express fimbriae was assayed by such criteria as immunoblotting, haemagglutination, electron and immunofluorescence microscopy. Immunoblotting employing anti-fimbrial serum of bacterial hosts that harboured the recombinant plasmids in most cases revealed the presence of chimeric proteins with the expected molecular masses (Fig. 4) . The most notable examples were pBSOl and pBSO2, encoding fimA genes with one or two heterologous inserts in position 25, respectively, which resulted in protein levels comparable to non-chimeric controls (pLBJ318). At the other end of the spectrum were strains from which very little or no recombinant protein could be observed, e.g. hosts containing plasmid pBSO7 with a single insert in position 105. The haemagglutination titres of host cells containing chimeric fimA-cholera genes were generally lower than those of comparable wild-type fimA controls (Table 2) .
Immunological detection of the cholera toxin epitope in the context of chimeric type 1 fimbriae
In Western blots of total lysates of host cells harbouring plasmids pBSO1-pBS07 chimeric FimA-CTB fimbriae were not recognized by specific anti-CTB serum. In the light of the fact that residues 50-64 form a conformational loop it is perhaps not surprising that this feature is not correctly re-folded in chimeric FimA-CTB proteins after extensive denaturation. It should be noted that this loop is indeed re-folded in the context of the parental protein, CTB (see later), however, the molecular environment of the loop present in the chimeras or in the parental molecular background is obviously quite different. Therefore, we investigated if the heterologous segments were authentically displayed directly on the bacteria. This was studied by CCD (chargecoupled device) microscopy in combination with fluorescent antibody methodology. By this technique E . coli hosts expressing chimeric FimA-CTB fimbriae were specifically recognized by serum raised against cholera toxin B subunit. Fig. 5 shows two representative examples of surface display of chimeric FimA proteins, harbouring a single and a tandem repeat of the heterologous sequence, respectively. In both cases the chimeric proteins are recognized by insert-specific antiserum. This demonstrates that the foreign epitopes are exposed on the surface of the host cells and, notably, in a conformation which mimics the natural conformation of the epitope in the context of the cholera toxin. We also investigated surface-localization and organelle assembly of the chimeric proteins by electron and immunoelectron microscopy (Fig. 6) . The data indicate that the chimeric proteins were specifically recognized on the surface of bacterial hosts by anti-CTB serum. The chimeric proteins were also, at least to some extent, assembled into fimbriae (Fig. 6c, e and g ).
Expression of chimeric fimbriae is dependent on the host background
In the present study we have investigated the expression of chimeric FimA and fimbriae in three different strains. One, MS7, is Afim, permitting us to investigate the ability of the introduced plasmids to confer fimbrial synthesis without interference from a chromosomally located fim gene cluster. The isogenic fim+ parent strain PC31, was used to provide information about the influence of a resident fim gene cluster on the plasmidencoded systems. Additionally, we employed a commensal isolate, DSM 6601, which is also fim' (Blum et af., 1995) . Comparing the MS7 and PC31 strains there seemed to be a tendency that a resident fim gene cluster provided a better background for expression of chimeric FimA proteins and fimbriae. For example, in the case of plasmid pBS02 a high level of chimeric protein was seen in immunoblotting in a PC31 background, whereas (25) fimA-BglII (45) fimA-BglII (80) fimA-BglII (105) fimA-cholera (25) fimA-cholera (45) fimA-cholera (80) fimA-cholera (105) fimA-2 x cholera (25) fimA-2 x cholera (45) fimA-2 x cholera (80) fimA-cholera (25) fimA-2 x cholera (25) fimA-cholera (45) fimA-2 x cholera (45) fimA-cholera (80) fimA-2 x cholera (80) fimA-cholera (105) fiin gene cluster replaced by a npt casette (cf.
Blum et a/. (1995) Klemm et al. (1985) Contains a pwf MS7 (M) and PC31 (P) hosts containing plasmid pBSO1-pBS07, pLBJ312, pLBJ318 and pBR322; 'pwf' indicates purified wildtype fimbriae. Rabbit anti-fimbrial serum was used as primary serum and peroxidasecoupled anti-rabbit serum was employed as secondary serum.
-FimA-cholera -w t FimA none was seen in the case of MS7 (Fig. 4) . Meanwhile , judging from all the criteria we have used, strain DSM 6601 is apparently the best host for expression of chimeric FimA proteins. With the exception of plasmid pBS07 all chimeric FimA proteins were expressed and exposed on the surface of DSM 6601. 
I m m u n ogen ici ty of c h i mer ic f i m b r iae
(:himeric FimA-CTB fimbriae were purified from hosts containing plasmid pBSOl (a single CTB segment in position 25), and used to immunize rabbits. As control one rabbit was immunized with wild-type fimbriae. Serum from animals immunized with the chimeric fimbriae was specifically able to recognize CTB in immunoblots, whereas serum from the control, immunized with wild-type fimbriae, was not (Fig. 7) .
DISCUSSION
In this study we have expressed the sequence of an important neutralizing epitope of CTB in localities of the FimA protein predicted to be surface-located. Our data demonstrate that this was indeed the case: the inserted cholera toxin epitope was presented in an antigenic configuration mimicking that in the toxin, and was exposed on the surface of the bacterial hosts. The (:TB segment was recognized in the context of chimeric Also, the chimeric proteins were to some extent polymerized into fimbriae (Fig. 6) . In one of the constructs, harbouring the heterologous insert in position 80, the chimeric protein was recognized by anti-CTB serum but not by anti-FimA monoclonal antibodies (mAbs) (Fig. 6c, e and g ). However, the mAbs were able to recognize wild-type FimA as well as chimeric FimA with an insert in position 25 ( Fig. 6a and h) . Consequently, the CTB insert in position 80 must either destroy or shield the specific epitope recognized by the niAbs. The CTB epitope present in the context of chimeric fimbriae also elicited a specific immune response in rabbits (Fig. 7) . wild-type fim gene cluster, the latter was clearly a better presenter of engineered versions of FimA. A multitude of factors, such as higher levels of chaperones and members of the general secretory pathway and lower levels of scavenging proteinases, might cause the DSM 6601 strain to be such an amenable host in this respect.
We believe that the fimbrial presentation system has a considerable potential, firstly because of the antigenamplification effect inherent in the fact that the major structural protein, and thereby the heterologous sequence, is present in large amounts predominantly on the bacterial surface (up to 500000 copies per cell in the wild-type situation). Surface presentation seems to be important for a strong immune-response in the context of live bacterial vaccines, e.g. in attenuated Salmonella strains it has been shown that a stronger immune response was elicited when the heterologous antigen was exposed on the bacterial surface (Hormaeche et af., 1992; Leclerc et af., 1991) . Secondly, fimbriae are easy to purify, a fact which might be relevant for a component vaccine approach.
The present system is an example of a strategy that has been pursued by several investigators in recent years, namely to use naturally occurring bacterial surface organelles for presentation of foreign epitopes. T w o major approaches, employing fimbriae and flagella, respectively, have been used to this end (Newton et al., 1989; Pallesen & Klernm, 1994; Wu et al., 1989 Fig, 6 . Double-labelled immunoelectron micrographs (a, c, e, g and h), showing labelling of FimA (5 nm) and the CTB segment on chimeric FimA (10 nm). Bacteria were adsorbed to the surface of the grid and incubated with a mixture of anti-CTB rabbit serum (1 : 100) and anti-FinnA monoclonal antibody (1 : 5). As secondary antibodies a mixture of goat antimouse serum conjugated with 5 nm colloidal gold particles and goat anti-rabbit serum conjugated with 10 nm colloidal gold particles were used in dilution 1 :20. Surface structures of the bacteria were analysed by shadow casting with tungsten a t an angle of 30" (b, d and f). logous segments of sizes up to, but not beyond, 20 amino acid residues (for review see Pallesen & Klemm, 1994 (b) chimeric FimA harbouring a CTB-segment in position 25 (serum dilution 1:250) and (c) CTB (serum dilution 1:40000). Three identical runs of CTB, chimeric FimA and wild-type FimA are shown in (a), (b) and (c).
fimbriae for display of heterologous sequences , and have, in this background succeeded in displaying even larger segments (58 amino acids). It might be that the FimH protein is able to accept larger heterologous grafts than FimA. However, one drawback of FimH is the lower ratio of this protein when integrated into the fimbriae; about a hundredfold less than FimA. The high valency display format provided by the FimA presentation system may be a significant advantage in vaccine design.
Future research will reveal whether a new generation of vaccines can be based on chimeric fimbriae or flagella, which fulfil the requirements for successful exposure and antigenicity of the heterologous epitopes while at the same time maintaining the functionality of the parental proteins.
